Eton Pharmaceuticals, Inc. (ETON)
Develops and sells medications for rare genetic and metabolic diseases.
$46.66+0.10%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+230.2%
The outlook
ETON trades at $46.66, near the top of its 52-week range and above both short and long-term moving averages. All four covering analysts rate it Strong Buy, with an average price target about 17% above current levels. The stock shows strong technical positioning and uniform analyst support.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 4 analysts
Price trendAbove its 50- & 200-day averages
52-week range99% of the way from its 52-week low to high
Price targetAvg target +17% vs current price
Analyst price target
~12-month · 4 analysts$54.75average target+17.3% vs now
Now $46.66
Low $40.00High $62.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.28B
52-wk high
$47.16
52-wk low
$13.78
50-day avg
$34.67
200-day avg
$23.09
Trailing P/E
—